Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Live vaccines for human metapneumovirus designed by reverse genetics.

Live vaccines for human metapneumovirus designed by reverse genetics. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Live vaccines for human metapneumovirus designed by reverse genetics. Abstract Text:

    ursula j buchholzUrsula J Buchholz,kunio nagashimaKunio Nagashima,brian r murphyBrian R Murphy,peter l collinsPeter L Collins,

    Human metapneumovirus (HMPV) was first described in 2001 and has quickly become recognized as an important cause of respiratory tract disease worldwide, especially in the pediatric population. A vaccine against HMPV is required to prevent severe disease associated with infection in infancy. The primary strategy is to develop a live-attenuated virus for intranasal immunization, which is particularly well suited against a respiratory virus. Reverse genetics provides a means of developing highly characterized 'designer' attenuated vaccine candidates. To date, several promising vaccine candidates have been developed, each using a different mode of attenuation. One candidate involves deletion of the G glycoprotein, providing attenuation that is probably based on reduced efficiency of attachment. A second candidate involves deletion of the M2-2 protein, which participates in regulating RNA synthesis and whose deletion has the advantageous property of upregulating transcription and increasing antigen synthesis. A third candidate involves replacing the P protein gene of HMPV with its counterpart from the related avian metapneumovirus, thereby introducing attenuation owing to its chimeric nature and host range restriction. Another live vaccine strategy involves using an attenuated parainfluenza virus as a vector to express HMPV protective antigens, providing a bivalent pediatric vaccine. Additional modifications to provide improved vaccines will also be discussed.

    Live vaccines for human metapneumovirus designed by reverse genetics. Publishing Authors By Initials

    uj buchholzUJ Buchholz,k nagashimaK Nagashima,br murphyBR Murphy,pl collinsPL Collins,

    For similar complex mixtures: biological products: vaccines: viral vaccines research abstracts see: complex mixtures: biological products: vaccines: viral vaccines research

    PUBMED ID PMID:

    MEDLINE DATE:

    Live vaccines for human metapneumovirus designed by reverse genetics. Journal Published:

    PUBLICATION TYPE: Review

    Journal: Expert review of vaccines

    VOLUME: 5

    Page Numbers: 695-706

    Journal Abbreviation:

    ISSN: 1744-8395

    DAY: 3

    MONTH: Oct

    YEAR: 2006

    Live vaccines for human metapneumovirus designed by reverse genetics. Information

    Number of References: 80

    LANGUAGE: eng

    NlmUniqueID: 101155475

    Live vaccines for human metapneumovirus designed by reverse genetics. Keywords Mesh Terms:

    KEYWORDS: Viral Vaccines

    MESH TERMS: immunology

    Chemical & Substance for Abstract: Live vaccines for human metapneumovirus designed by reverse genetics. Information

    Substance Name: Viral Vaccines

    Registry Number: 0

    Grant and Affiliation Information for Live vaccines for human metapneumovirus designed by reverse genetics.

    AFFILIATION: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 50, Room 6505, 50 South Dr. MSC 8007, Bethesda, MD 20892-8007, USA. ubuchholz@niaid.nih.gov

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NCI

    GRANT: N01-CO-12400

    ACRONYM: CO

    MEDLINETA: Expert Rev Vaccines

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Live vaccines for human metapneumovirus designed by reverse genetics Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News